Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹25 Cr₹61 Cr₹101 Cr₹135 Cr₹143 Cr

What is the latest Total Non-Current Liabilities ratio of NATCO PHARMA ?

The latest Total Non-Current Liabilities ratio of NATCO PHARMA is ₹25 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹25 Cr
Mar2024₹61 Cr
Mar2023₹101 Cr
Mar2022₹135 Cr
Mar2021₹143 Cr

How is Total Non-Current Liabilities of NATCO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹25 Cr
-59.18
Mar2024 ₹61 Cr
-39.30
Mar2023 ₹101 Cr
-25.61
Mar2022 ₹135 Cr
-5.46
Mar2021 ₹143 Cr -

Compare Total Non-Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,491.5 Cr -3.1% 3% -11.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,711.0 Cr -0.8% 3.5% 14.7% Stock Analytics
DIVIS LABORATORIES ₹192,376.0 Cr -1% 7.3% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,655.0 Cr -0.9% 10.1% 44.6% Stock Analytics
CIPLA ₹113,979.0 Cr -2.1% -1.8% -6% Stock Analytics
DR REDDYS LABORATORIES ₹96,204.7 Cr -5.8% -13.2% -7.7% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-3.1%

3%

-11.1%

SENSEX

-2.7%

-0.2%

-8%


You may also like the below Video Courses